Features
- FDA has granted MITA a breakthrough device designation (Q210093). We are in consultations with FDA on a path toward MITA becoming a Class II medical device.
- MITA is protected by patent US 20160210870.
- Includes unlimited language and cognitive exercises designed to last for 10 years
- Used by over 2 million children with language delay
- Best Autism App on the Healthline’s list
- Available in English, Spanish, Portuguese, Russian, German, French, Italian, Arabic, Farsi, Korean, and Chinese.
*If this is not the "
Language and Cognitive Therapy for Children – early intervention game-like exercises for children " product you were looking for, you can check the other results by
clicking this link
.
Details were last updated on Apr 27, 2025 10:36 +08.
.
Details were last updated on Apr 27, 2025 10:36 +08.
